4D Molecular Therapeutics, Inc. (FDMT) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $85.21M | +230194.6% |
| 2024 | $37.0K | -99.8% |
| 2023 | $20.72M | +562.3% |
| 2022 | $3.13M | -82.7% |
| 2021 | $18.04M | +35.0% |
| 2020 | $13.36M | +92.0% |
| 2019 | $6.96M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $85.21M | +230194.6% |
| 2024 | $37.0K | -99.8% |
| 2023 | $20.72M | +562.3% |
| 2022 | $3.13M | -82.7% |
| 2021 | $18.04M | +35.0% |
| 2020 | $13.36M | +92.0% |
| 2019 | $6.96M | — |